Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
Karyopharm fosters a fast-paced environment that rewards hard workers.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
You feel valued at Karyopharm
Quelles sont les meilleures choses à propos de votre équipe?
Our team is highly collegial; we all strive to be high achievers, but aren't competitive with each other in a negative way.
Qu’est-ce qui vous rend le plus heureux au travail?
The interpersonal relationships and the being empowered to "follow my passion" by exploring new professional responsibilities that I might not have any experience in.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
The leadership team sets the company priorities in such a way that we're all clear on the core missions of the company and its portfolio.
Quelle est la meilleure partie de votre programme de rémunération?
The company knows that the way you show appreciation in the 21st century is with a generous compensation package, and Karyopharm puts their money where their mouth is.
Other Employee Reviews for Karyopharm Therapeutics
×